To be honest Hawk70 the funs just about to start. The donkeys that are selling pennies below their cash funding are very special. The company is worth less than its funding keep posting.
Once they announce GLP shortly and then move into phase 1 human trials for both traumatic brain injury and stroke which lines up with Walter Reed and further 5-10 million in non dilutive funding. You have a drug that works, safe and a 60 billion target market the first of its kind.
Relax Hawk70 you load up just before phase 1 coming up and then run it into phase 2. You’re the genius like you said last time.
Ann: NYR Signs Strategic Partnership with US Brain Injury Company, page-40
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.040(61.5%) |
Mkt cap ! $19.13M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 14.5¢ | 9.2¢ | $1.422M | 12.21M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 42093 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30678 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |